Phase III Melphalan Trial Shows Improvement in Hepatic-PFS in Melanoma Patients with Liver Metastases December 25, 2015Vol.38 No.12
Onivyde Combination Boosts OS in Post-Gemcitabine Pancreatic Cancer Patients December 25, 2015Vol.38 No.12
Drugs & Targets FDA Approves Opdivo Injection for Renal Cell Carcinoma Patients December 25, 2015Vol.38 No.12
AML Patients Receiving PKC412 Midostaurin Show 23% OS Improvement in Phase III Trial December 25, 2015Vol.38 No.12
Head-to-Head Phase III Study Demonstrates Kyprolis Nearly Doubles PFS over Velcade December 25, 2015Vol.38 No.12
TCGA Researchers Identify 7 Subtypes of Prostate Cancer and 2 Drivers of Papillary RCC November 30, 2015Vol.38 No.11
Researchers: All Pediatric Patients, Regardless of Family History, Could Benefit from Genomic Screening November 30, 2015Vol.38 No.11
ICT-107 Boosts Overall Survival by 10 Percent In Phase II Glioblastoma Trial November 30, 2015Vol.38 No.11
Lenalidomide-Rituximab Combination Shows Benefits in Mantle Cell Lymphoma November 30, 2015Vol.38 No.11
